BENSALEM, Pa., Dec. 6, 2024 /PRNewswire/ — Law Offices of Howard G. Smith continues its investigation on behalf of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) investors concerning the Company’s possible violations of federal securities laws. On April 10,…